TEMOZOLOMIDE 180 mg Pill: brown & white, capsule/oblong, 22mm
The pill with imprint TEMOZOLOMIDE 180 mg (Brown & White, Capsule/Oblong, 22mm) has been identified as Temozolomide 180 mg and is used for Glioblastoma Multiforme, and Anaplastic Astrocytoma. It belongs to the drug class alkylating agents and is not a controlled substance.
Images for TEMOZOLOMIDE 180 mg
Temozolomide
- Imprint
- TEMOZOLOMIDE 180 mg
- Strength
- 180 mg
- Color
- Brown & White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- IDT Australia Limited
- National Drug Code (NDC)
- 64144-0505
- Inactive Ingredients
-
lactose anhydrous,
sodium starch glycolate type A potato,
silicon dioxide,
stearic acid,
tartaric acid,
gelatin,
methylparaben,
propylparaben,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Yellow No. 6,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "TEMOZOLOMIDE 180 mg"
Featured
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Reviews & ratings
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.